» Articles » PMID: 29866502

Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond

Overview
Specialty Endocrinology
Date 2018 Jun 6
PMID 29866502
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Growth differentiation factor-15 (GDF15) is a circulating protein that has been implicated in multiple biological processes, including energy homeostasis, body weight regulation, and cachexia driven by cancer and chronic disease. The potential to target GDF15 in the treatment of energy-intake disorders, including obesity and anorexia, is an area of intense investigation, but has been limited by the lack of an identified receptor, signaling mechanism, and target tissue. GDNF family receptor α-like (GFRAL) was recently identified as the neuronal brainstem receptor responsible for mediating the anorectic actions of GDF15. Herein, we provide a brief overview of GDF15 biology with a focus on energy homeostasis, and highlight the implications of the recent receptor identification to this field and beyond.

Citing Articles

Alterations in Biomarkers Associated with Cardiovascular Health and Obesity with Short-Term Lifestyle Changes in Overweight Women: The Role of Exercise and Diet.

Sengun N, Pala R, Cinar V, Akbulut T, Larion A, Padulo J Medicina (Kaunas). 2025; 60(12.

PMID: 39768899 PMC: 11727739. DOI: 10.3390/medicina60122019.


The clinical utility in hospital-wide use of growth differentiation factor 15 as a biomarker for mitochondrial DNA-related disorders.

Fernandez A, Estrella J, Oglesbee D, Larson A, Van Hove J J Inherit Metab Dis. 2024; 48(1):e12821.

PMID: 39582258 PMC: 11671288. DOI: 10.1002/jimd.12821.


Different roles of circulating and intramuscular GDF15 as markers of skeletal muscle health.

Chiariello A, Conte G, Rossetti L, Trofarello L, Salvioli S, Conte M Front Endocrinol (Lausanne). 2024; 15:1404047.

PMID: 38808117 PMC: 11130406. DOI: 10.3389/fendo.2024.1404047.


Analysis of the Associations of Measurements of Body Composition and Inflammatory Factors with Cardiovascular Disease and Its Comorbidities in a Community-Based Study.

Tarabeih N, Kalinkovich A, Ashkenazi S, Cherny S, Shalata A, Livshits G Biomedicines. 2024; 12(5).

PMID: 38791028 PMC: 11117926. DOI: 10.3390/biomedicines12051066.


Growth Differentiation Factor 15 and Diet Quality Trajectory Interact to Determine Frailty Incidence among Middle-Aged Urban Adults.

Beydoun M, Noren Hooten N, Fanelli-Kuczmaski M, Maino Vieytes C, Georgescu M, Beydoun H J Nutr. 2024; 154(5):1652-1664.

PMID: 38479650 PMC: 11130674. DOI: 10.1016/j.tjnut.2024.03.006.